CDAP offers an array of alcohol and substance abuse clinical services forming a continuum of patient care.
The Center for Drug and Alcohol Programs intensive outpatient program provides treatment for people suffering from addiction to drugs and/or alcohol who have completed detoxification or who do not require hospitalization. The dynamic outpatient format involves patients in recovery-oriented activities across several days a week.
The intensive outpatient program is comprehensive, incorporating recovery skills, education, individual and group therapy. Family participation is incorporated into our program and is strongly encouraged. Our treatment model draws upon evidence-based treatment modalities, including cognitive-behavioral therapy, motivational interviewing, twelve-step facilitation, and medication management. Our psychiatrists and counselors are highly skilled, and use a variety of medical, behavioral and psychological interventions proven by experience and research to effectively reduce the chances of relapse and to maximize the benefits of treatment.
Patients can enter the intensive outpatient program treatment at any time. Upon entry to the program, clients are assigned to one of our individual clinicians, who work with clients to help tailor the program to meet their unique treatment goals. All clients receive a thorough evaluation at treatment onset to build rapport and guide treatment planning. During the four weeks of the program, clients also work with their clinicians to develop an aftercare plan for maintaining recovery. This follow-up plan may include a less intensive schedule of further individual or group therapy to reinforce specific treatment goals. Long-term disease management is encouraged through booster sessions with your individual clinician, to reinforce recovery efforts and facilitate growth in sober living skills.
The intensive outpatient program groups meet each weekday from 9 a.m. to noon. Our program is enhanced with Wednesday evening relapse prevention groups, in which current program attendees participate alongside graduates of the program as part of our thriving recovery community. Call 843-792-5200 to learn more about our outpatient services
The Center for Drug and Alcohol Programs outpatient clinic offers individual treatment sessions for those suffering from addiction to alcohol or other drugs. Following an initial evaluation, clients are assigned to a clinician who provides individual treatment that is rooted in evidence-based practices. Our team of psychiatrists are available to treat patients with the latest addiction medications designed to reduce cravings and decrease the chances of relapse.
CDAP offers a Buprenorphine Maintenance Clinic for opiate dependent patients. This clinic consists of medical management of opiate withdrawal symptoms and cravings, along with group psychotherapy. These services are delivered by addiction psychiatrists and addiction counselors operating in conjunction with each patient to achieve optimal outcomes.
The Center for Drug and Alcohol Programs offers confidential addictions evaluations and treatment for medical and legal professionals. The CDAP staff works regularly with professional associations and licensing boards to assure optimum care and recovery for referred persons.
CDAP helps family members, friends, employers and co-workers of addicted persons to discuss, plan and implement onsite interventions to facilitate treatment.
Alcohol blood tests and urine drug screening tests help clinicians monitor each patient’s progress during treatment. These tests also provide valuable feedback to patients and alert the clinician to potential relapse problems.
Biomarker tests for excessive alcohol use include gamma glutamyltransferase (GGT) and, a newer test, carbohydrate deficient transferrin (%dCDT). These are simple blood tests that can indicate if a patient has been drinking over the recent past. For example, if %dCDT test results are high, this indicates that a patient has probably been drinking at least 5 standard alcoholic drinks per day for the past two weeks or longer. The %dCDT test is correct in identifying heavy drinking in 9 out of 10 individuals.
Screening for specific drugs is conducted via urine samples. Screening can be conducted on the presence of amphetamine, methamphetamine, barbiturates, benzodiazepines, cannabinoid, cocaine, opiates and PCP.
Since the Center for Drug and Alcohol Programs conducts a number of clinical trials investigating new pharmacological and psychosocial treatments for addiction, some individuals may decide to receive treatment as part of this research. However, individuals must meet certain qualifications to be included in these studies and not everyone qualifies.
View a list of current clinical trials.
For information about CDAP addictions treatment services or to schedule an appointment, call, 843-792-2727.
Progressnotes: Spring 2016
Charleston Alcohol Research Center turns 21
MUSC News Center - February 11, 2016
$7M NIH grant for MUSC alcohol research center funds innovative treatments